Olainfarm says a change in its strategy has delivered an increase in sales March despite an overall decline in the first quarter of 2020. Turnover in Ukraine shot up as a result of a new distribution alliance.
Latvia’s Olainfarm group says changing its strategy has helped it to reverse a downward trend in the first quarter of 2020, with its results for the month of March alone showing sales growth of more than a fifth and contrasting with the turnover drop of almost a tenth seen for the firm across the entire three-month period.
Olainfarm reported consolidated sales of €13.2m ($14.3m) for March 2020, representing a year-on-year increase of 22%. Domestic sales improved by...
Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
